Today’s AI Top Pick: ADMA

ADMA is the cleanest fundamental + forecast combo in this pool. The fundamentals are elite for a $2.18B healthcare name: PE 13.8, fwdPe 10.3, PEG 0.46, ROE 41.9%, operating margin 42.26%, profit margin 32.98%, debtEq 0.5, analyst recom 1.33 with a 92.1% consensus upside — that is the highest expected return in the entire screen (79.7%) paired with a fundamental_score of 8. It has also been beaten up (YTD -46.71%, 1yr -42.86%), so we are buying an already-washed-out name that still prints 33% net margins, not chasing strength. The tape confirms across the timeframes that matter for a swing entry. Kronos bullish_prob is 1.0 and near_term_bullish is 0.8. The 4h forecast is exceptional (fc_short +59.0%, fc_mid +65.5%, fc_long +87.9%) and the 1d confirms with fc_mid +35.5% / fc_long +49.3%. Multi-timeframe agreement on 4h and 1d is strong, and the 21-bar drawdown of only -1.64% on 4h / -4.47% on 1d says the trend is intact — we are not buying at a broken level. Yes, the weekly is soft (fc_mid -8.6%, pos 49.85%), but that is exactly what you want when the daily/4h are turning up: a base that has not yet participated, leaving room for a weekly breakout. Entry today makes sense because the recent Aug-5 earnings miss has already been digested (stock reset lower and has since stabilized) and the Aug-12 Seeking Alpha thesis explicitly called out remaining upside after the reset — plus Ascentiv +24% growth in Q2 is a real catalyst underneath the headline miss. Position in 21-bar range is 88.6% on 4h but only 71.9% on 1d and 49.9% on 1wk, meaning we are not extended on the timeframe that matters for a multi-week hold. Compared to PDD (pos 100% on 4h — chasing), CALX (pos 94.8%), ORCL (weekly fc -11.5% and near_term_bullish only 0.2), and WAY (weaker fundamentals with ROE 3.77%), ADMA is the one where great fundamentals, strong forecasts, and non-extended weekly setup all line up.